tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Eagle Pharmaceuticals's activity chart (see below) currently has 72 price targets and 60 ratings on display.
Analysts average stock forecasts to be materialized ratio is 78.09% with an average time for these price targets to be met of 170.2 days.
Most recent stock forecast was given by DAVID AMSELLEM from PIPER SANDLER on 08-Aug-2023. First documented stock forecast 09-Mar-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$17
$15.7 (1207.69%)
$31
3 years 1 months 6 days ago
(08-Aug-2023)
7/10 (70%)
$-2.23 (-11.60%)
64
Hold
$33
$31.7 (2438.46%)
$50
3 years 6 months 2 days ago
(12-Mar-2023)
3/4 (75%)
$7.49 (29.36%)
90
Buy
4 years 5 months 18 days ago
(27-Mar-2022)
1/1 (100%)
$46.76 (113.39%)
395
Buy
$57
5 years 5 months 8 days ago
(06-Apr-2021)
4/8 (50%)
$13.88 (32.19%)
168
Hold
$41
$25.23 (159.99%)
$52
7 years 5 months 24 days ago
(22-Mar-2019)
21/22 (95.45%)
$0.44 (0.83%)
134
What is EGRX (Eagle Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on EGRX (Eagle Pharmaceuticals)?
Which analyst has the current lower performing score on EGRX (Eagle Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on EGRX (Eagle Pharmaceuticals)?
Which analyst is the currently most bullish on EGRX (Eagle Pharmaceuticals)?
Which analyst is the currently most reserved on EGRX (Eagle Pharmaceuticals)?
